Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma / Bhave, P; Ahmed, T; Lo, Sn; Shoushtari, A; Zaremba, A; Versluis, Jm; Mangana, J; Weichenthal, M; Si, L; Lesimple, T; Robert, C; Trojanello, C; Wicky, A; Heywood, R; Tran, L; Batty, K; Dimitriou, F; Stansfeld, A; Allayous, C; Schwarze, Jk; Mooradian, Mj; Klein, O; Mehmi, I; Roberts-Thomson, R; Maurichi, A; Yeoh, Hl; Khattak, A; Zimmer, L; Blank, Cu; Ramelyte, E; Kahler, Kc; Roy, S; Ascierto, P; Michielin, O; Lorigan, Pc; Johnson, Db; Plummer, R; Lebbe, C; Neyns, B; Sullivan, R; Hamid, O; Santinami, M; Mcarthur, Ga; Haydon, Am; Long, Gv; Menzies, Am; Carlino, Ms. - In: JOURNAL FOR IMMUNOTHERAPY OF CANCER. - ISSN 2051-1426. - 10:7(2022). [10.1136/jitc-2022-004668]

Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma

Ascierto P;
2022

2022
Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma / Bhave, P; Ahmed, T; Lo, Sn; Shoushtari, A; Zaremba, A; Versluis, Jm; Mangana, J; Weichenthal, M; Si, L; Lesimple, T; Robert, C; Trojanello, C; Wicky, A; Heywood, R; Tran, L; Batty, K; Dimitriou, F; Stansfeld, A; Allayous, C; Schwarze, Jk; Mooradian, Mj; Klein, O; Mehmi, I; Roberts-Thomson, R; Maurichi, A; Yeoh, Hl; Khattak, A; Zimmer, L; Blank, Cu; Ramelyte, E; Kahler, Kc; Roy, S; Ascierto, P; Michielin, O; Lorigan, Pc; Johnson, Db; Plummer, R; Lebbe, C; Neyns, B; Sullivan, R; Hamid, O; Santinami, M; Mcarthur, Ga; Haydon, Am; Long, Gv; Menzies, Am; Carlino, Ms. - In: JOURNAL FOR IMMUNOTHERAPY OF CANCER. - ISSN 2051-1426. - 10:7(2022). [10.1136/jitc-2022-004668]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1014301
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 61
  • ???jsp.display-item.citation.isi??? 60
social impact